loading page

Clinical characteristics and perinatal outcomes of women with COVID-19 in Wuhan: retrospective case series
  • +5
  • Hao Zeng,
  • Yujie Liu,
  • Lan Dong,
  • Qifan Zhang,
  • Shengmin Zhao,
  • Luowen Xin,
  • Panwen Tian,
  • Zhixin Huang
Hao Zeng

Corresponding Author:[email protected]

Author Profile
Qifan Zhang
Author Profile
Shengmin Zhao
Author Profile
Luowen Xin
Author Profile
Panwen Tian
Author Profile
Zhixin Huang
Author Profile

Abstract

Background This study was undertaken to evaluate the clinical characteristics and perinatal outcomes of pregnant women with COVID-19 in different trimesters and to determine the possibility of vertical transmission of the disease. Methods Medical records of 25 consecutive pregnant women with laboratory-confirmed COVID-19 who were admitted to Renmin Hospital of Wuhan University, Wuhan, China, from Feb 1 to Mar 20, 2020 were reviewed. Results Eleven cases were in early and middle pregnancy, and 14 cases were in late pregnancy. Seven of 25 women (28.0%) had mild disease, 15 (60.0%) had moderate disease, and 3 (12.0%) had severe disease. The most common symptoms of patients were fever (48.0%) and cough (48.0%), though 7 (28.0%) of them were asymptomatic at admission. Fever was more prevalent in early and middle pregnancy than in late pregnancy (72.7% vs. 28.6%, P=0.028). Among patients in early and middle pregnancy, there were 1 spontaneous abortion and 3 induced abortions, but no intrauterine growth restriction was observed among ongoing pregnancies. All 14 patients in late pregnancy underwent a cesarean section, with 4 premature deliveries (28.6%). No neonatal asphyxia or death was recorded. Nasopharyngeal swab samples from 6 neonates were tested for SARZ-CoV-2, and all were negative. In one neonate, the anal swab was positive for SARS-CoV-2, and IgG and IgM were increased. Conclusions The clinical characteristics of COVID-19 in early and middle pregnant women were similar to those in late pregnancy. There is a potential risk of vertical transmission in SARS-CoV-2.